Filter announcements
Loading...
Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services
Bal Pharma Limited has clarified that it possesses no undisclosed price-sensitive information or material updates that could account for recent significant fluctuations in its share price. The company confirmed that all necessary disclosures have been made on time and maintained full compliance with mandatory requirements. Management stated that the observed...
Bal Pharma has allotted 1,000,000 convertible warrants at ₹84 each to promoter Shailesh Siroya, aggregating to ₹8.40 Cr, raising 25% upfront (₹2.10 Cr). Warrants are convertible into equity within 18 months, boosting his potential stake from 17.24% to 20.89%.
Bal Pharma has set September 17, 2026, as the Record Date for its final dividend. Eligible shareholders will receive Rs. 1.20 per share for FY2025-26, which is 12% of the face value. The dividend will be paid on or after September 24, 2026. Ensure your bank and PAN details are...
Bal Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
Bal Pharma announced its 39th Annual General Meeting. The company also fixed the record date for shareholder eligibility for the proposed final dividend for FY25-26 and the cut-off date for e-voting. Book closure details were specified.